Biomarkers of cardiovascular stress and incident chronic kidney disease. - Wikidata - awgldk - TriplyDB

Biomarkers of cardiovascular stress and incident chronic kidney disease.

Biomarkers of cardiovascular stress and incident chronic kidney disease.

http://www.wikidata.org/entity/Q37678391

about

GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability Emerging risk biomarkers in cardiovascular diseases and disorders GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers.Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia.Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study MAP3K11/GDF15 axis is a critical driver of cancer cachexia Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis.Growth Differentiation Factor-15 and Risk of CKD Progression.Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction

P2860

Q26798142-B6E03227-9D46-407F-9DC1-ACB348CAEA00 Q28081407-FB7817FC-7D94-4575-950E-30770646F485 Q28081614-1ED643DD-E86E-4D2B-A688-4C09F8A214D3 Q33362887-B0A4D75C-D953-40E0-91D5-F6DAD2098947 Q34110286-12A5C6E1-7425-49A6-B14E-581511A706F8 Q35051193-23136B13-5CA4-4EB7-935A-73CA1D3A9924 Q35224090-6206F210-24B8-4586-B654-20D046C9554F Q36090550-50B7871B-1AE8-49AD-818F-17FC5802F6FF Q36347479-AECBF40A-DC78-4C78-9D95-F3B8158D4C9D Q36621007-6CE8E2AA-14EA-4C08-A738-000A4ACFEBFD Q36779000-71F9F585-3A8E-4663-BF6C-25635C3FFD34 Q36892019-C971A3BE-4A5B-4B76-AB50-20C33EC785F6 Q37681556-9A6CD4B0-59BE-445F-A8EE-7C58509E60F9 Q47213170-7A77AFC1-520B-4605-AA1D-E6D2C348DD35 Q51153601-F7F7A6F0-F82B-4D62-AC3C-7F2859B065AA Q54979361-58CD4C35-3FC9-4F6F-96F6-643B59BCE11B Q58580704-616239E4-D5F4-4D81-9097-29DD09037D41

P2860

Biomarkers of cardiovascular stress and incident chronic kidney disease.

http://www.wikidata.org/entity/Q37678391

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@en

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@nl

type

label

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@en

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@nl

prefLabel

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@en

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@nl

P1433

Q37678391-A174B0A3-4CF7-4E13-B77C-098139FA75FD

P1476

Q37678391-95088B15-1C24-4D11-BBC7-1C7A13EAE83A

P2093

Q37678391-180ACB80-A015-4FD1-AC16-0851D066DA47

Q37678391-303265EC-3EB0-40E9-83D2-B8FA29D8220A

Q37678391-65379200-A722-4079-85DC-246375AC9952

Q37678391-656FB9C6-5A32-48E4-B327-A5781D721677

Q37678391-A343B70F-4D2A-4B09-88AE-108AD083EE98

Q37678391-D1D411B5-71CA-4609-B6A3-B027AE3E1D0A

Q37678391-FE0E6064-1E25-4F0B-9F53-3B8B3F28425A

P2860

Q37678391-005A9A99-DD86-42AD-A535-CAD18C14A54B

Q37678391-0302FD6F-47D1-404A-A579-D9730D2C3BCA

Q37678391-0A590DE7-6B54-4D4B-A942-017E8553BF2D

Q37678391-22EF6534-3001-46A4-A750-C290C2298B42

Q37678391-28C2DE47-6B78-4F4D-B8B4-C7B4FDB51660

Q37678391-32131496-031A-428A-848F-7E81323A3F51

Q37678391-3F370776-C680-4074-A46F-88E8AD22236C

Q37678391-49D4F8F4-B382-4803-9FF5-D71AF6E9762E

Q37678391-4ECD9CED-CD4E-49F5-8759-8EC758C4F47D

Q37678391-53B424D9-438A-4213-9118-93CBD7C10B87

P304

Q37678391-045E08B2-BC26-47D6-A799-4DC4C9419A17

P31

Q37678391-2FD1AF14-93BB-48C2-A1B3-CFBFD194F9F3

P356

Q37678391-784D9E2C-392E-48D4-A194-1A5ABD75BC80

P407

Q37678391-658987E7-F266-4CA7-8FB6-5E1817C74C37

P433

Q37678391-B63263F3-0E17-4AB9-BAED-B0F836E4D7DB

P478

Q37678391-905161B7-6283-443F-8553-9AE054C9CCEA

P50

Q37678391-6F3D34AD-3FB5-4A50-A71C-9638336AB3A2

Q37678391-85075F84-0DE9-44DE-988E-4FD1F323D178

Q37678391-C216B913-4557-4825-A105-26EDC3E4E679

P577

Q37678391-138E1CAB-72C7-44AD-B318-D9C1E3F61990

P5875

Q37678391-B3B1545A-F2C0-4AC6-B2A3-C4A4287669B5

P698

Q37678391-DF7E4B7B-4FB1-4CE0-954F-90A1F2548D63

P921

Q37678391-366A69C3-9FE9-4D37-92BA-8C2C1927BC4B

Q37678391-994417BB-FD25-40E6-A098-F0D56A3E20EB

P932

Q37678391-CDA36D88-FB27-4B96-946B-423D13E14F59

P356

CLINCHEM.2013.205716

P1433

Clinical Chemistry

P1476

Biomarkers of cardiovascular stress and incident chronic kidney disease.

@en

P2093

Caroline S Fox

http://www.w3.org/2001/XMLSchema#string

Kai C Wollert

http://www.w3.org/2001/XMLSchema#string

Martin G Larson

http://www.w3.org/2001/XMLSchema#string

Shih-Jen Hwang

http://www.w3.org/2001/XMLSchema#string

Susan Cheng

http://www.w3.org/2001/XMLSchema#string

Thomas J Wang

http://www.w3.org/2001/XMLSchema#string

Tibor Kempf

http://www.w3.org/2001/XMLSchema#string

P2860

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

A new equation to estimate glomerular filtration rate

Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Inflammation and atherosclerosis

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.

Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.

Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

P304

1613-1620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2013.205716

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Ramachandran S. Vasan

James L Januzzi

P577

2013-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250925262

http://www.w3.org/2001/XMLSchema#string

P698

23873716

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3972213

http://www.w3.org/2001/XMLSchema#string